deVries Tina Marie 4
4 · RVL Pharmaceuticals plc · Filed May 20, 2022
Insider Transaction Report
Form 4
deVries Tina Marie
EVP, Research & Development
Transactions
- Tax Payment
Ordinary Shares
2022-05-18$1.40/sh−5,447$7,626→ 136,141 total
4 · RVL Pharmaceuticals plc · Filed May 20, 2022
Ordinary Shares